PROTEIN CONFORMATION

蛋白质构象

基本信息

  • 批准号:
    6593393
  • 负责人:
  • 金额:
    $ 31.28万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-06-01 至 2003-04-30
  • 项目状态:
    已结题

项目摘要

The appearance of structural modifications in proteins is a well documented symptom of biological aging which can be used to study the latter process. The major goal of this project is to collect data on age-sensitive measures of protein status in a cohort of 600 UM-HET3 mice to provide information about map positions on loci that influence protein function, and to test for suggestive correlations between protein status and other structural and functional indices of aging rate. The project focuses on two proteins, the glycolytic enzyme phosphoglycerate kinase (PGK) and the eye lens proteins, in particular the chaperone-protein alpha-crystallin. These two protein systems have very different structures, biological and physical characteristics, but both are altered by aging in mice. The specific aims of Project 4 include: 91) To examine thermal inactivation rate and immunotitration data for PGK in brain, heart and liver in the 600 mice of Population 1. Thermal inactivation rate decline sup to 7-fold between 6 and 27 months in rats, while immunologically abnormal PGK appear to various ages in most tissues. (2) To quantitate the extent of modification of eye lens proteins in these 600 mice by optical techniques with sensitivity to changes in molecular weight, in structure and in spectroscopic signatures, to be applied both to intact lenses and to extracted lens proteins. (3) The same battery of tests will be performed ont he genetically selected (and control) mice in Population 2 to see in alleles that alter longevity also influence protein conformation and cross-linking. In addition to providing information about genes that may control these age-sensitive traits, our data should help to determine whether inter-animal differences in protein status might contribute to functional changes in age-sensitize tissues (bone, muscle, immune system) and whether protein functional status is likely to be regulated by oxidation and glycoxidation processes addressed in Project 5. The comparisons, which can only be made in the context of a multi- disciplinary program project, will test our hypothesis that biochemical signatures that correlate with older age will be associated with other age-sensitize phenotypes and be under over-lapping genetic control. In addition to the above listed aims, which pertain to the Program as a whole, Project 4 will also address the following project-specific issues: 1. Test whether the increased aggregation-propensity of proteins in the old eye lens is due to a reduction in the protection afforded by alpha-crystallin. 2. Search for the molecular origin of the age-related loss in alpha-crystallin's efficacy as a chaperone protein. 3. Develop and test additional experimental approaches for protein-modifications- studies, to be applied in future Program work.
蛋白质结构改变的出现是生物老化的一个有据可查的症状,可用于研究后者的过程。该项目的主要目标是收集600只UM-HET 3小鼠队列中蛋白质状态的年龄敏感指标数据,以提供有关影响蛋白质功能的基因座上的图谱位置的信息,并测试蛋白质状态与衰老率的其他结构和功能指标之间的暗示性相关性。该项目的重点是两种蛋白质,糖酵解酶磷酸甘油酸激酶(PGK)和眼透镜蛋白,特别是伴侣蛋白α-晶状体蛋白。这两种蛋白质系统具有非常不同的结构,生物学和物理特性,但两者都因小鼠的衰老而改变。项目4的具体目标包括:91)检查种群1的600只小鼠脑、心脏和肝脏中PGK的热灭活率和免疫滴定数据。在6 ~ 27月龄的大鼠中,PGK热灭活率下降高达7倍,而免疫异常在大多数组织中出现于不同年龄。(2)通过对分子量、结构和光谱特征变化具有灵敏度的光学技术定量测定这600只小鼠中眼透镜蛋白的修饰程度,并将其应用于完整晶状体和提取的透镜蛋白。(3)将对群体2中的遗传选择(和对照)小鼠进行相同的测试,以观察改变寿命的等位基因是否也影响蛋白质构象和交联。除了提供有关可能控制这些年龄敏感性状的基因的信息外,我们的数据还有助于确定蛋白质状态的动物间差异是否可能导致年龄敏感组织(骨骼,肌肉,免疫系统)的功能变化,以及蛋白质功能状态是否可能受到项目5中提到的氧化和糖基化过程的调节。只能在多学科计划项目的背景下进行的比较将检验我们的假设,即与老年相关的生化特征将与其他年龄敏感表型相关,并受到重叠的遗传控制。除了上述与整个计划有关的目标外,项目4还将解决以下项目特有的问题:1.测试老年人透镜中蛋白质聚集倾向的增加是否是由于α-晶状体蛋白提供的保护减少所致。2.寻找与年龄相关的α-晶状体蛋白作为伴侣蛋白功效丧失的分子起源。3.开发和测试蛋白质修饰研究的其他实验方法,以应用于未来的计划工作。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ARI GAFNI其他文献

ARI GAFNI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ARI GAFNI', 18)}}的其他基金

A Single Molecule Study of Amyloid Beta Neuronal Toxicity
β淀粉样蛋白神经元毒性的单分子研究
  • 批准号:
    7777812
  • 财政年份:
    2009
  • 资助金额:
    $ 31.28万
  • 项目类别:
Single Molecule Approach to Neurodegeneration in Alzheimer's Disease
单分子方法治疗阿尔茨海默病神经退行性疾病
  • 批准号:
    7930613
  • 财政年份:
    2009
  • 资助金额:
    $ 31.28万
  • 项目类别:
Single Molecule Approach to Neurodegeneration in Alzheimer's Disease
单分子方法治疗阿尔茨海默病神经退行性疾病
  • 批准号:
    7729850
  • 财政年份:
    2009
  • 资助金额:
    $ 31.28万
  • 项目类别:
Michigan Molecular Biophysics Training Program
密歇根分子生物物理学培训计划
  • 批准号:
    7902701
  • 财政年份:
    2009
  • 资助金额:
    $ 31.28万
  • 项目类别:
A Single Molecule Approach to neurodegeneration in AD
治疗 AD 神经变性的单分子方法
  • 批准号:
    7267949
  • 财政年份:
    2006
  • 资助金额:
    $ 31.28万
  • 项目类别:
Single Molecule Studies of IAPP Oligomer Formation and Membrane Permeabilization
IAPP 寡聚物形成和膜透化的单分子研究
  • 批准号:
    7230068
  • 财政年份:
    2006
  • 资助金额:
    $ 31.28万
  • 项目类别:
Single Molecule Studies of IAPP Oligomer Formation and Membrane Permeabilization
IAPP 寡聚物形成和膜透化的单分子研究
  • 批准号:
    7074118
  • 财政年份:
    2006
  • 资助金额:
    $ 31.28万
  • 项目类别:
A Single Molecule Approach to neurodegeneration in AD
治疗 AD 神经变性的单分子方法
  • 批准号:
    7142101
  • 财政年份:
    2006
  • 资助金额:
    $ 31.28万
  • 项目类别:
BIOCHEMISTRY CORE
生物化学核心
  • 批准号:
    6480655
  • 财政年份:
    2002
  • 资助金额:
    $ 31.28万
  • 项目类别:
PROTEIN CONFORMATION
蛋白质构象
  • 批准号:
    6458989
  • 财政年份:
    2001
  • 资助金额:
    $ 31.28万
  • 项目类别:

相似海外基金

Pyrrole-Modified Porphyrins: Platforms to Probe the Malleability of Porphyrinoid Conformation and Aromaticity
吡咯修饰的卟啉:探测类卟啉构象的延展性和芳香性的平台
  • 批准号:
    2400038
  • 财政年份:
    2024
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Standard Grant
CAREER: Controlling Chain Conformation in Amorphous Polymers through Soft Nanoscale Confinement
职业:通过软纳米级限制控制非晶态聚合物的链构象
  • 批准号:
    2339425
  • 财政年份:
    2024
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Continuing Grant
Hyper-Raman Spectroscopic Investigation of Protein Conformation Associated with Osmolytes and Water Molecules
与渗透物和水分子相关的蛋白质构象的超拉曼光谱研究
  • 批准号:
    24K17652
  • 财政年份:
    2024
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
smFRET analysis of TDP-43 conformation under the effect of Hero proteins
Hero蛋白作用下TDP-43构象的smFRET分析
  • 批准号:
    22KJ0814
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
"Painting" the 3D proteome: folding, conformation and interactions
“绘制”3D 蛋白质组:折叠、构象和相互作用
  • 批准号:
    DP230101050
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Discovery Projects
Computational Development of Novel Dyslipidemia Therapeutic Candidates to Disrupt ApoC-III Conformation
破坏 ApoC-III 构象的新型血脂异常治疗候选物的计算开发
  • 批准号:
    10760187
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
Protein conformation, Protein misfolding, hIAPP, Ion mobility mass spectrometry
蛋白质构象、蛋白质错误折叠、hIAPP、离子淌度质谱
  • 批准号:
    2869746
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Studentship
Conformation, Automation and Applications of Polyborons in Synthesis
聚硼的构象、自动化及其在合成中的应用
  • 批准号:
    EP/Y028015/1
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Research Grant
Roles of Heme and Protein Conformation in Ligand Binding Cooperativity and Selectivity in Bacterial Globin Coupled Sensors
血红素和蛋白质构象在细菌球蛋白耦合传感器中配体结合协同性和选择性中的作用
  • 批准号:
    2312149
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Standard Grant
Development to ultra-early diagnosis and prevention of AD by using a specific antibody against the toxic conformation of amyloid beta
利用针对β淀粉样蛋白毒性构象的特异性抗体开发AD超早期诊断和预防
  • 批准号:
    23H00325
  • 财政年份:
    2023
  • 资助金额:
    $ 31.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了